Intellectus Partners LLC Raises Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Intellectus Partners LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,164 shares of the exchange traded fund’s stock after buying an additional 425 shares during the period. Intellectus Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,005,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of XBI. Howard Capital Management Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 2.6% during the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after purchasing an additional 6,188 shares during the last quarter. Graypoint LLC boosted its position in shares of SPDR S&P Biotech ETF by 5.6% in the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after purchasing an additional 146 shares during the period. Advisor Resource Council purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $260,000. Verity Asset Management Inc. increased its position in SPDR S&P Biotech ETF by 0.9% during the third quarter. Verity Asset Management Inc. now owns 20,089 shares of the exchange traded fund’s stock worth $1,985,000 after buying an additional 179 shares during the period. Finally, Equitable Trust Co. purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $211,000.

SPDR S&P Biotech ETF Trading Up 0.3 %

XBI stock opened at $87.30 on Friday. The company has a market capitalization of $5.76 billion, a P/E ratio of 11.47 and a beta of 0.93. The business has a 50 day simple moving average of $90.57 and a 200-day simple moving average of $95.46. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.